451 related articles for article (PubMed ID: 32469296)
1. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
[No Abstract] [Full Text] [Related]
2. Three-Year Results of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Infrapopliteal Arteries.
Varcoe RL; Thomas SD; Lennox AF
J Endovasc Ther; 2018 Dec; 25(6):694-701. PubMed ID: 30205736
[TBL] [Abstract][Full Text] [Related]
3. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.
Varcoe RL; Schouten O; Thomas SD; Lennox AF
JACC Cardiovasc Interv; 2016 Aug; 9(16):1721-8. PubMed ID: 27539693
[TBL] [Abstract][Full Text] [Related]
4. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
[TBL] [Abstract][Full Text] [Related]
5. Mid-term outcomes of an everolimus-eluting bioresorbable vascular scaffold in patients with below-the-knee arterial disease: A pooled analysis of individual patient data.
Huizing E; Kum S; Ipema J; Varcoe RL; Shah AP; de Vries JP; Ünlü Ç
Vasc Med; 2021 Apr; 26(2):195-199. PubMed ID: 33507844
[TBL] [Abstract][Full Text] [Related]
6. Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease.
Dia A; Venturini JM; Kalathiya R; Besser S; Estrada R; Friant J; Paul J; Blair JE; Nathan S; Shah AP
Catheter Cardiovasc Interv; 2019 Dec; 94(7):1028-1033. PubMed ID: 31617294
[TBL] [Abstract][Full Text] [Related]
7. Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: a real-world single-center experience.
AbuRahma AF; Beasley M; Davis M; Adams E; Lee A; Shapiro J; Dean LS; Davis E
J Vasc Surg; 2021 Nov; 74(5):1619-1625. PubMed ID: 34182023
[TBL] [Abstract][Full Text] [Related]
8. Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease.
Dia A; Venturini JM; Kalathiya RJ; Besser S; Estrada JR; Friant J; Paul J; Blair JE; Nathan S; Shah AP
Vascular; 2021 Jun; 29(3):355-362. PubMed ID: 32921290
[TBL] [Abstract][Full Text] [Related]
9. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
10. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
[No Abstract] [Full Text] [Related]
12. Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.
Lammer J; Bosiers M; Deloose K; Schmidt A; Zeller T; Wolf F; Lansink W; Sauguet A; Vermassen F; Lauwers G; Scheinert D; Popma JJ; McGreevy R; Rapoza R; Schwartz LB; Jaff MR
JACC Cardiovasc Interv; 2016 Jun; 9(11):1178-87. PubMed ID: 27282601
[TBL] [Abstract][Full Text] [Related]
13. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
Huntress LA; Fereydooni A; Dardik A; Nassiri N
Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
[TBL] [Abstract][Full Text] [Related]
14. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
[TBL] [Abstract][Full Text] [Related]
16. Outcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia.
Bosiers MJ; Deloose K; Peeters P; Torsello G; Zeller T; Scheinert D; Schmidt A; Maene L; Keirse K; Varcoe R; Bosiers M
J Cardiovasc Surg (Torino); 2017 Feb; 58(1):49-54. PubMed ID: 27455888
[TBL] [Abstract][Full Text] [Related]
17. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
18. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
[TBL] [Abstract][Full Text] [Related]
19. Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study.
Schmidt A; Schreve MA; Huizing E; Del Giudice C; Branzan D; Ünlü Ç; Varcoe RL; Ferraresi R; Kum S
J Endovasc Ther; 2020 Aug; 27(4):658-665. PubMed ID: 32419597
[No Abstract] [Full Text] [Related]
20. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
